Evidence map›Paper›PMID 41493666›Full record

ArticleGlycoconjugate journal2026

SPR interaction analysis of GM3 glycan with the integrin α5β1 head domain.

Shinya Hanashima, Migiwa Kishi, Katsuaki Sasaki, Yusuke Sato, Michio Murata

Abstract read
PubMed Publisher
In one paragraph

Article in Glycoconjugate journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shinya HanashimaGraduate School of Science, Osaka University, Machikaneyama 1-1, Toyonaka, Osaka, 560-0043, Japan. hanashima@tottori-u.ac.jp.
Migiwa KishiGraduate School of Science, Osaka University, Machikaneyama 1-1, Toyonaka, Osaka, 560-0043, Japan.
Katsuaki SasakiGraduate School of Science, Osaka University, Machikaneyama 1-1, Toyonaka, Osaka, 560-0043, Japan.
Yusuke SatoDepartment of Chemistry and Biotechnology, Graduate School of Engineering, Tottori University, Koyamacho-minami 4-101, Tottori, 680-8550, Japan.
Michio MurataGraduate School of Science, Osaka University, Machikaneyama 1-1, Toyonaka, Osaka, 560-0043, Japan.

Funding

Japan Science and Technology Corporation JPMJCR18H2Japan Society for the Promotion of Science JP23K17373Japan Society for the Promotion of Science JP23K17993Japan Society for the Promotion of Science JP24K17801
6 · The paper itself

Abstract

Integrins are heterodimeric receptors involved in cell adhesion and bidirectional signaling. Ganglioside GM3 in the outer leaflet of cell membranes possibly regulates integrin activity via direct interactions; however, its specific binding mode with integrins remains unclear. Therefore, in this study, we focused on the GM3 glycan moiety, which encounters the integrin ectodomain on the cell surface, and synthesized a soluble GM3 probe without hydrocarbon chains using a chemoenzymatic approach. Binding analysis using surface plasmon resonance (SPR) indicated that the synthetic GM3 probe interacts with the integrin α5β1 ectodomain with a significantly higher affinity than the lactosylceramide probe. Saturation transfer difference (STD) NMR spectra suggested that the integrin α5β1 ectodomain interacts with N-acetylneuraminic acid (Neu5Ac) at the GM3 terminal and α2-3Gal linkage. Notably, RGD peptide, an integrin ligand interacting with the heterodimer interface, competed with GM3 to bind to integrin α5β1 on the SPR sensor chip. Consistent with these results, the GM3-binding site predicted by Chai-1 partially overlapped with the RGD peptide-binding groove on integrin α5β1; however, the binding mode was different. RGD peptide bridged the α and β subunits of the integrin head moiety, whereas the GM3 probe found at the cleft between the subunits. The Neu5Ac-Gal moiety primarily interacts with the metal ion-dependent adhesion site and nearby residues in the β1 subunit. Overall, our findings suggest that gangliosides directly interact with integrin α5β1 at a previously unknown binding site, revealing a novel regulatory mechanism for the integrin activity.

Indexed as

G(M3) GangliosideIntegrin alpha5beta1Binding SitesHumansProtein BindingProtein DomainsSurface Plasmon ResonanceG(M3) GangliosideIntegrin alpha5beta1Chemoenzymatic synthesisDocking studyGangliosideIntegrinSPR

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.